Press release
Intravenous Immunoglobulin Market: Rising Demand for IVIG Therapy Drives Market Growth and Therapeutic Advancements
Rising Demand: IVIG is used for the treatment of various conditions, including primary immunodeficiency disorders, chronic inflammatory demyelinating polyneuropathy (CIDP), Guillain-Barré syndrome (GBS), and immune thrombocytopenic purpura (ITP). The growing awareness about the benefits of IVIG therapy and advancements in healthcare infrastructure are leading to an increased demand for IVIG products.
Therapeutic Applications: IVIG is extensively used in the treatment of immune deficiencies, particularly primary immunodeficiency disorders (PIDD). It is also employed in the management of autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus (SLE), and dermatomyositis. Additionally, IVIG is used for neurological disorders like Alzheimer's disease, multiple sclerosis, and myasthenia gravis.
Increasing Research and Development: Pharmaceutical companies are investing in research and development activities to develop improved formulations and delivery methods for IVIG products. This includes the development of subcutaneous IVIG, which offers advantages such as reduced infusion time and increased patient convenience.
Competitive Landscape: The IVIG market is characterized by the presence of several key players, including pharmaceutical companies and biotechnology firms. Some prominent companies in this market include CSL Behring, Grifols, Kedrion Biopharma, Octapharma, and Takeda Pharmaceuticals. These companies are focusing on expanding their product portfolios, geographical presence, and strategic collaborations to gain a competitive edge.
Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/325
Market Drivers:
Increasing Prevalence of Immunodeficiency Disorders: The rising incidence and prevalence of primary immunodeficiency disorders (PIDD) are driving the demand for IVIG. PIDDs are a group of genetic disorders that impair the immune system's ability to defend against infections. IVIG therapy helps replace the deficient antibodies in individuals with PIDD, thereby boosting their immune response.
Growing Awareness and Diagnosis of Autoimmune Diseases: Autoimmune diseases, such as rheumatoid arthritis, systemic lupus erythematosus (SLE), and multiple sclerosis, are becoming increasingly prevalent worldwide. IVIG is used in the treatment of these conditions to modulate the immune response and reduce disease activity. The growing awareness and improved diagnostic techniques for autoimmune diseases are leading to an increased demand for IVIG.
Expansion of Therapeutic Applications: IVIG has shown efficacy in treating an expanding range of conditions beyond immunodeficiency and autoimmune diseases. It is used in the management of neurological disorders like Guillain-Barré syndrome (GBS), chronic inflammatory demyelinating polyneuropathy (CIDP), myasthenia gravis, and Alzheimer's disease. The widening therapeutic applications of IVIG are driving its market growth.
Request for Customization - https://www.alliedmarketresearch.com/request-for-customization/325
Market Segmentation:
Indication:
a. Primary Immunodeficiency Disorders (PIDD): IVIG is extensively used for the treatment of various primary immunodeficiency disorders, including X-linked agammaglobulinemia, common variable immunodeficiency (CVID), and selective IgA deficiency.
b. Autoimmune Diseases: IVIG is employed in the management of autoimmune conditions such as rheumatoid arthritis, systemic lupus erythematosus (SLE), and dermatomyositis.
c. Neurological Disorders: IVIG is utilized for the treatment of neurological conditions like Guillain-Barré syndrome (GBS), chronic inflammatory demyelinating polyneuropathy (CIDP), myasthenia gravis, and Alzheimer's disease.
Formulation:
a. Liquid IVIG: The most common form of IVIG is the liquid formulation, which is available in various concentrations and administered via intravenous infusion.
b. Lyophilized IVIG: Lyophilized or freeze-dried IVIG requires reconstitution with sterile water before administration. It offers advantages such as extended shelf life and ease of storage.
End User:
a. Hospitals and Clinics: IVIG therapy is predominantly administered in hospitals and outpatient clinics, where healthcare professionals can closely monitor patients during the infusion process.
b. Homecare Settings: With the development of subcutaneous IVIG formulations, there is an increasing trend of IVIG administration in homecare settings, allowing patients to receive treatment in the comfort of their homes.
Geography:
The IVIG market can be segmented based on geographical regions, such as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Each region may have different market dynamics influenced by factors such as healthcare infrastructure, reimbursement policies, regulatory frameworks, and patient demographics.
Distribution Channel:
a. Hospital Pharmacies: IVIG products are commonly procured and distributed through hospital pharmacies.
b. Retail Pharmacies: Some IVIG products may also be available through retail pharmacies, enabling patients to fill prescriptions and access IVIG treatment conveniently.
These segmentation categories help in analyzing the market, understanding specific patient needs, and tailoring marketing strategies to target different customer segments effectively.
Procure Complete Report : https://www.alliedmarketresearch.com/purchase-enquiry/325
Competitive Landscape:
CSL Behring
Grifols
Takeda Pharmaceuticals
Kedrion Biopharma
Octapharma
Baxter International Inc.
China Biologic Products Holdings, Inc.
Shire (now part of Takeda Pharmaceuticals)
Biotest AG
LFB Group
Related Reports :
Medical Implant Market
Advanced Wound Care Market
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com
Allied Market Research Blog: https://blog.alliedmarketresearch.com
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Intravenous Immunoglobulin Market: Rising Demand for IVIG Therapy Drives Market Growth and Therapeutic Advancements here
News-ID: 3148163 • Views: …
More Releases from Allied Market Research
Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
The global urinary drainage bags market is experiencing robust growth, with its market size valued at $1.4billion in 2021 and projected to reach $2billion by 2031. This expansion represents a compound annual growth rate (CAGR) of 3.8% from 2021 to 2031, highlighting the increasing demand for these essential medical devices.
Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/A17529
What Are Urinary Drainage Bags?
Urinary drainage bags are specialized medical devices designed to collect…
Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
The global cream powder industry was estimated at $4.8 billion in 2021 and is expected to hit $8.9 billion by 2031, registering a CAGR of 6.4% from 2022 to 2031.
The cream powder market is experiencing growth due to various factors, including the increasing popularity of bakeries and HoReCa (hotels, restaurants, and cafes) and rising consumer demand for natural products. The dairy-based segment is a significant contributor to the market's growth…
Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Bil …
The global micro drone industry generated $6.71 billion in 2020, and is expected to reach $28.91 billion in 2030, witnessing a CAGR of 17.2% from 2021 to 2030. The report provides an extensive analysis of changing market dynamics, top segments, top investment pockets, regional landscape, value chain, and competitive scenario.
Increased operational efficiency and rise in demand for improved surveillance drive the growth of the global micro drone market. However, strict…
Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of …
The global microwaveable foods industry was accounted for $120.45 billion in 2020, and is expected to reach $230.93 billion by 2031, growing at a CAGR of 5.6% from 2022 to 2031.
Rise in popularity of fast-food restaurants and large population base coupled with increase in number of quick-service restaurants drive the global microwaveable foods market. However, lack of awareness about microwavable foods hinders the market growth. On the contrary, rise in…
More Releases for IVIG
IVIg Powder Market 2022-2028 Global Key Manufacturers' Analysis Review
The "Global IVIg Powder Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the IVIg Powder market with detailed market segmentation by drug class and distribution channel. The report provides key statistics on the market status of the leading IVIg Powder market players and offers key trends…
Intravenous Immunoglobulin (IVIG) Market Size, Share | Industry Report 2026
The global Intravenous Immunoglobulin Market was valued at $13.7Billion in 2018 and is forecast to grow at a modestxx.3 % CAGR between 2018 and 2026, culminating in 2026 global sales of $16.7Billion.
Intravenous Immunoglobulin (IVIG) is a solution of highly purified immunoglobulin G, derived from large human plasma that contains antibodies against a broad spectrum of bacterial and viral agents. Intravenous immunoglobulin of properties isa composition that addition of albumin,…
Intravenous Immunoglobulin (IVIG) Market: Rising Prevalence of Neurological Dise …
This report on the global intravenous immunoglobulin (IVIG) market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails.
Secondary research…
Intravenous Immunoglobulin (IVIG) Market: Rising Production of IVIG Products are …
The global market for intravenous immunoglobulin (IVIG) products and therapies is heading in a positive direction due to several innovative techniques and advantages it offers to clinicians worldwide. The market is expected to expand at a healthy pace in the near future. Factors that will support market’s growth include technological improvements in the methods used for production and purification of IVIG products and an improving health care infrastructure across the…
Global Intravenous Immunoglobulin (IVIg) Market
The Intravenous Immunoglobulin Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
The term “immunoglobulin” refers to the breakdown of blood plasma that contains antibody. IVIg is a blood product which is administered intravenously. It contains polyvalent IgG antibodies which are extracted from…
Global Intravenous Immunoglobulin (IVIG) Market: Rising Patient Pool of Neurolog …
The global intravenous immunoglobulin (IVIG) market is largely consolidated, with top four players: Grifols S.A., CSL Behring LLC, Baxalta Incorporated, and Octapharma AG, accounting for over 70% of the overall market in 2015. Grifols S.A. accounted for the dominant share of 23.0%, chiefly on account of the company’s strong geographic penetration.
Oligopoly in the market has led to intense competition among top players and has compelled companies to take course of…
